Pelthos Therapeutics Inc. (PTHS) investor relations documents from the company's IR site: 1 presentation, 16 press releases; latest deck 2026-05-13. Read in-app with summaries. First-party data.
Investor Presentation: Pelthos Therapeutics is a commercial-stage dermatology company focused on cutaneous infections, anchored by its flagship molluscum treatment, Zelsuvmi.
PTHS overview · PTHS earnings · PTHS financials · PTHS KPIs · PTHS ownership · PTHS peers · PTHS filings
Documents published by the company on its investor-relations site; summaries are model-written. Not personalized investment advice.